What is NVIDIA Parabricks?
NVIDIA® Parabricks® is distinguished as the only comprehensive suite of genomic analysis tools that utilizes GPU acceleration to deliver swift and accurate genome and exome assessments for a variety of users, including sequencing facilities, clinical researchers, genomics scientists, and developers of high-throughput sequencing technologies. This cutting-edge platform incorporates GPU-optimized iterations of popular tools employed by computational biologists and bioinformaticians, resulting in significantly enhanced runtimes, improved scalability of workflows, and lower computing costs. Covering the full spectrum from FastQ files to Variant Call Format (VCF), NVIDIA Parabricks markedly elevates performance across a range of hardware configurations equipped with NVIDIA A100 Tensor Core GPUs. Genomics researchers can experience accelerated processing throughout their complete analysis workflows, encompassing critical steps like alignment, sorting, and variant calling. When users deploy additional GPUs, they can achieve near-linear scaling in computational speed relative to conventional CPU-only systems, with some reporting acceleration rates as high as 107X. This exceptional level of efficiency establishes NVIDIA Parabricks as a vital resource for all professionals engaged in genomic analysis, making it indispensable for advancing research and clinical applications alike. As genomic studies continue to evolve, the capabilities of NVIDIA Parabricks position it at the forefront of innovation in this rapidly advancing field.
Integrations
Similar Software to NVIDIA Parabricks
Lockbox LIMS
A cloud-based Laboratory Information Management System (LIMS) is designed to oversee sample tracking, test outcomes, and inventory management specifically for life sciences research, industrial quality control laboratories, and biotechnology/next-generation sequencing applications. This comprehensive system provides essential regulatory compliance support for standards such as CLIA, HIPAA, Part 11, and ISO 17025, ensuring that laboratories operate within the necessary legal frameworks. The importance of quality, security, and traceability in managing samples cannot be overstated, as these factors play a pivotal role in a lab's effectiveness and reliability. Utilizing the Lockbox LIMS platform, laboratory professionals gain the ability to meticulously oversee their samples, offering complete transparency throughout the entire process, from initial accession to long-term preservation. Additionally, LIMS analysis encompasses far more than merely tracking outcomes; the Lockbox system features advanced multilayered sample storage capabilities and location management, allowing users to customize their laboratory's storage framework with diverse options that include rooms, storage units, shelves, racks, and boxes. This flexibility empowers labs to efficiently organize and access their samples, ultimately enhancing operational productivity and accuracy.
Learn more
SAP S/4HANA Cloud Public Edition
SAP S/4HANA Public Cloud serves as an advanced ERP solution that facilitates rapid digital transformation through AI-driven insights, adherence to industry standards, and an intuitive user experience. By enhancing operational efficiency, empowering decision-making, and revealing new avenues for growth, it stands out as a comprehensive tool for modern businesses.
Key features include compliance with SOX and GAAP, robust financial controls, detailed forecasting and reporting, and effective treasury and tax management. Additionally, it offers automation through AI, machine learning, and robotic process automation, alongside efficient supply chain and inventory management solutions. With templated integrations and strong manufacturing capabilities, it supports scalability for businesses of all sizes.
Embracing industry innovation is essential to propel growth in revenue, efficiency, and profitability. Continuous improvement is the cornerstone of optimizing business operations and processes, ensuring that organizations stay competitive in their respective markets. Therefore, selecting a dedicated partner who is committed to your success is crucial in navigating this journey.
Learn more
Illumina DRAGEN Secondary Analysis
The DRAGEN Secondary Analysis system from Illumina provides accurate, comprehensive, and exceptionally efficient processing of next-generation sequencing data. By leveraging a graph reference genome in combination with machine learning methodologies, it achieves outstanding precision. With a highly streamlined workflow, it can fully analyze a 34x whole human genome in roughly 30 minutes when operated on the DRAGEN server v4. Furthermore, it optimizes this process by reducing FASTQ file sizes by as much as five times. This system is proficient in handling diverse types of NGS data, such as whole genomes, exomes, methylomes, and transcriptomes. It has been designed to work seamlessly with the user's chosen platform and can scale to accommodate various needs. DRAGEN analysis is consistently recognized as a frontrunner in accuracy for detecting both germline and somatic variants, supported by its strong performance in industry competitions hosted by precisionFDA. This sophisticated analytical tool enables laboratories of all sizes and specialties to fully leverage their genomic datasets. Additionally, the integration of highly adaptable field-programmable gate array (FPGA) technology allows DRAGEN to implement hardware-accelerated genomic analysis algorithms, significantly improving its efficiency. These advancements firmly establish DRAGEN as an essential asset in the rapidly advancing realm of genomics, enabling researchers to push the boundaries of scientific discovery.
Learn more
AWS HealthOmics
Seamlessly integrate multiomic data from patients with their health histories to deliver personalized healthcare strategies. Leverage dedicated data repositories that support in-depth analysis and collaborative research efforts across diverse population groups. Accelerate research initiatives by adopting scalable methodologies and robust computational resources. Prioritize patient confidentiality by adhering to HIPAA regulations and implementing thorough data access controls. AWS HealthOmics aids healthcare providers and life science organizations, along with their software partners, in the efficient storage, querying, and analysis of genomic, transcriptomic, and various omics datasets, ultimately producing actionable insights that improve health outcomes and drive scientific advancements. Oversee and evaluate omics data for a wide array of patients to identify trends in omics variability relative to phenotypic characteristics within a community. Develop organized and verifiable clinical multiomics workflows to reduce waiting periods and enhance operational efficiency. Incorporate multiomic evaluations into clinical trials for the assessment of new drug candidates, thereby laying the groundwork for cutting-edge treatments and therapies. This data integration not only improves the quality of research but also cultivates a more profound understanding of the complex relationships between genetics and overall health, leading to potentially revolutionary discoveries in medical science. Through these concerted efforts, the potential for breakthroughs in patient care and treatment options significantly increases.
Learn more
Screenshots and Video
Company Facts
Company Name:
NVIDIA
Date Founded:
1993
Company Location:
United States
Company Website:
www.nvidia.com/en-us/clara/genomics/
Product Details
Deployment
SaaS
Training Options
Documentation Hub
Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English